C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 233/36 (2006.01) A61K 31/454 (2006.01) A61K 31/495 (2006.01) A61K 31/517 (2006.01) A61P 29/00 (2006.01) C07D 239/80 (2006.01) C07D 263/58 (2006.01) C07D 277/82 (2006.01) C07D 401/06 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2543419
The present invention relates to compounds of Formula (I), wherein R2, R3, R4, R9, Ar, UC, X, Y, Q, n and p are as defined in the specification. The compounds are useful as CCR-3 receptor antagonists, and therefore, may be used for treatment of CCR-3 mediated diseases.
La présente invention concerne des composés de formule (I), dans laquelle R?2¿, R?3¿, R?4¿, R?9¿, Ar, U<SB>C</SB>, X, Y, Q, n et p sont tels que définis dans le mémorandum descriptif. Ces composés sont utiles comme antagonistes du récepteur CCR-3, et peuvent donc être employés pour le traitement de maladies induites par CCR-3.
Gong Leyi
Wilhelm Robert Stephen
Borden Ladner Gervais Llp
F. Hoffmann-La Roche Ag
LandOfFree
Ccr3 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ccr3 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ccr3 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2026217